BIO89-100
89bio
[]
pegozafermin 27 mg - an fg21 analogue - once every wk in pts with severe hypertiglyceridemia (&gt;500 mg/dl) lowers triglycerides by 50-60% &amp; non hdl by 20-30%, improves hdl &amp; insulin resistance &amp; reduces liver fat in the entrigue trial #esc2022 
cardiology, coronary intervention, echocardiography and valvular heart disease